Liu Z F, Hu X T, Feng X, Li H B
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2017 Sep 5;31(17):1327-1329. doi: 10.13201/j.issn.1001-1781.2017.17.007.
Allergic rhinitis and its impact on asthma (ARIA) has been the most preferred reference for national guidelines. The ARIA 2010 revision is the first evidence-based clinical guideline in the field of allergies, which has great influence in the world. The ARIA 2016 revision continues the basic framework of the 2010 revision, which focuses on six controversial clinical issues in the treatment of allergic rhinitis.It aimed to provide clear informationand systematic treatment for patients, clinicians and health policy makers. The interpretation of the ARIA 2016 revision will help domestic otolaryngologist, respiratory doctors, and allergy practitioners understand the latest guidelines for AR drug treatment in the world.
变应性鼻炎及其对哮喘的影响（ARIA）一直是各国指南最青睐的参考依据。《ARIA 2010修订版》是过敏领域首个循证临床指南，在全球具有重大影响力。《ARIA 2016修订版》延续了2010年修订版的基本框架，重点关注变应性鼻炎治疗中六个有争议的临床问题，旨在为患者、临床医生和卫生政策制定者提供清晰的信息和系统的治疗方案。对《ARIA 2016修订版》的解读将有助于国内耳鼻喉科医生、呼吸科医生及过敏症从业者了解全球变应性鼻炎药物治疗的最新指南。
